Results from a phase II trial of conformal radiation therapy for pediatric patients with localized low-grade astrocytoma and quantification of radiation-related CNS effects
Thomas E. Merchant(St. Jude Children's Research Hospital), Robert A. Sanford(University of Illinois Urbana-Champaign), Erin N. Kiehna(Novant Health), Amar Gajjar(St. Jude Children's Research Hospital), Raymond K. Mulhern(St. Jude Children's Research Hospital), Thomas Williams(University of Edinburgh), L. Kun(Radiation Oncology Associates), S. Wu(St. Jude Children's Research Hospital), Fredrick A. Boop(St. Jude Children's Research Hospital), X. Xiong(St. Jude Children's Research Hospital)
Cited by 1
Related Papers
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
|The Lancet|1991|387
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
|Journal of Clinical Oncology|1996|353